Abstract:Genome-wide association studies (GWASs) have identified dozens of susceptibility loci for sporadic Alzheimer's disease (AD) primarily in Caucasians, but whether the same or different variants account for genetic risks in Chinese remains unknown. A two-stage case-control GWAS was conducted for subjects from 39 hospitals across China. In the discovery stage, 993 AD cases and 6,451 controls passed quality control after genotyping using Illumina HumanOmniZhongHua-8 BeadChips. In the replication stage, 55 top single nucleotide polymorphisms (SNPs) with evidence of associations and eight SNPs previously reported in Caucasians were selected for genotyping using ABI PRISM® SNaPshot™ Multiplex System in an independent cohort of 1,201 AD cases and 4,889 controls. In the combined analysis, seven SNPs had associations exceeding the genome-wide significance threshold (P < 5.0 × 10−8) with no heterogeneity between stages. The overall variance was calculated using the restricted maximum-likelihood method. HaploReg, cis-expression quantitative trait loci (cis-eQTL) database, the Gene Expression Omnibus (GEO) profiles, STRING, and the Gene Ontology enrichment analysis was used to further characterize these seven variants. For the APOE region, multifactor regression analysis using imputed data was performed. Four novel variants were identified with genome-wide significance (P < 5 × 10-8): rs463717 (5q31.3, Pcombined = 8.56 × 10-15), rs11625699 (14q13.1, Pcombined = 4.80 × 10-20), rs3784616 (15q21.1, Pcombined = 2.34 × 10-25), and rs16980322 (19q13.32, Pcombined = 2.75 × 10-21). Additionally, APOE rs405509 (Pcombined = 9.53 × 10-28), PVRL2 rs4803766 (Pcombined = 1.91 × 10-18), and PVRL2 rs387976 (Pcombined = 9.90 × 10-11) were associated with AD. These seven variants explained 15.87% of the overall variance in disease risk. For the eight previously reported SNPs selected for detection in the replication stage, only rs2070045 of SORL1 showed significant associations. Multifactor regression analysis using imputed data in APOE region found previously reported AD-associated SNPs in Caucasians remained significant in Chinese. The present GWAS identified four novel susceptibility variants for AD. The genes located near the four novel variants are functionally related to neurogenesis, suggesting neurogenesis in AD pathogenesis. This study also suggests genetic heterogeneity of AD susceptibility in Chinese and Caucasian populations. Regional association plots. Association results are shown for the analyzed SNPs with recombination rates in the four loci associated with genome-wide significance at 5q31.3 (a), 14q13.1 (b), 15q21.1 (c) and 19q13.32 (d-e). Purple diamonds represent the most significantly associated SNP in the combined analysis. The quantile-quantile (Q-Q) plot of the association results from the discovery stage analysis (993 AD cases and 6,451 controls). Displayed are observed versus expected -log10 P values for all variants. The yellow line indicates the expected distribution of - log10 P values under the null hypothesis. The plot in purple is for SNPs excluding previously reported SNPs with P > 10-12 (λGC = 1.038).

Genome-Wide Association and Interaction Study on Quantitative Traits of CSF Phosphorylated Tau in ADNI Cohort.

FOUR NOVEL SUSCEPTIBILITY VARIANTS IDENTIFIED IN CHINESE ARE ASSOCIATED WITH SPORADIC ALZHEIMER’S DISEASE

Genome-wide Association and Interaction Studies of CSF T-tau/Aβ42 Ratio in ADNI Cohort.

Genome-Wide Epistasis Study of Cerebrospinal Fluid Hyperphosphorylated Tau in ADNI Cohort.

Genome-wide epistasis analysis reveals gene–gene interaction network on an intermediate endophenotype P-tau/Aβ42 ratio in ADNI cohort

A Novel Method Based on Linear Regression Model for Identify the Sensitivity of Quantitative Trait in ADNI Cohort

A genome-wide association study of longitudinal change in CSF tau among non-demented elderly

Identifying Potential Genetic Epistasis Implicated in Alzheimer's Disease Via Detection of SNP-SNP Interaction on Quantitative Trait CSF Aβ42.

SNPs Associated with Cerebrospinal Fluid Phospho-Tau Levels Influence Rate of Decline in Alzheimer's Disease

Genome-wide Network-Based Pathway Analysis of CSF T-Tau/aβ1-42 Ratio in the ADNI Cohort

Network-based Analysis Approach to Prioritize GWAS of CSF in the ADNI Cohort

Genome‐wide association study of ADNI QT‐PAD biomarkers identifies a novel locus on Chr 12: Developing topics

X chromosome-wide association study of quantitative biomarkers from the Alzheimer's Disease Neuroimaging Initiative study

Integrate GWAS, Eqtl, and Mqtl Data to Identify Alzheimer’s Disease-Related Genes

Proteome-wide association studies using summary pQTL data of three tissues identified 30 risk genes of Alzheimer's disease dementia

Genetic Interactions Explain Variance in Cingulate Amyloid Burden: an AV-45 PET Genome-Wide Association and Interaction Study in the ADNI Cohort

A GPU-based Approach for Detecting Genome-Wide SNP-SNP Interactions of Quantitative Trait in ADNI Cohorts.

Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer's disease

Multivariate genome wide association and network analysis of subcortical imaging phenotypes in Alzheimer's disease

Genome-wide scan of Flortaucipir PET levels finds associated with cerebral tau deposition

Genome-wide Association Study of Brain Tau Deposition As Measured by 18F-Flortaucipir Positron Emission Tomography Imaging.